MedTrace Logo

OptiGon - Optimising Laboratory Assays for Immune Responses to Gonococcus

NCT05613725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2024-05-21

No results posted yet for this study

Summary

This is an observational study. Blood from otherwise healthy patients presenting with confirmed N.gonorrhoea infection, prior to treatment, will be collected to (i) allow the optimisation of assays assessing the immune response to gonococcus and (ii) assess whether N. gonorrhea specific responses can be detected on ELIspot +/- flow cytometry.

The investigators plan to recruit up to 30 adults (men and women, aged 18-50 years) who have been diagnosed with confirmed N.gonorrhoea infection at the Sexual Health Clinic at the Oxford University Hospitals NHS Foundation Trust. The investigators will collect blood samples from consenting participants prior to them receiving curative antibiotic treatment.

Conditions

  • Gonorrhea

Interventions

OTHER

Blood sample collection

Blood sample collection

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Calman MacLennan · University of Oxford

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-02
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05613725 on ClinicalTrials.gov